---
document_datetime: 2023-09-21 20:07:06
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/duzallo-epar-all-authorised-presentations_en.pdf
document_name: duzallo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1460352
conversion_datetime: 2025-12-24 02:55:37.536081
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented)   | Strength      | Pharmaceutical Form   | Route of       | Immediate Packaging               | Pack size   |
|------------------|--------------|---------------|-----------------------|----------------|-----------------------------------|-------------|
|                  | name         |               |                       | Administration |                                   |             |
| EU/1/18/1300/001 | Duzallo      | 200 mg/200 mg | Film-coated tablet    | Oral use       | blister (PVC/PVDC/alu)            | 30 tablets  |
| EU/1/18/1300/002 | Duzallo      | 200 mg/200 mg | Film-coated tablet    | Oral use       | blister (PVC/PVDC/alu)            | 100 tablets |
| EU/1/18/1300/003 | Duzallo      | 300 mg/200 mg | Film-coated tablet    | Oral use       | blister (PVC/PVDC/alu) authorised | 30 tablets  |
| EU/1/18/1300/004 | Duzallo      | 300 mg/200 mg | Film-coated tablet    | Oral use       | blister (PVC/PVDC/alu)            | 100 tablets |
| EU/1/18/1300/005 | Duzallo      | 200 mg/200 mg | Film-coated tablet    | Oral use       | blister (PVC/PVDC/alu)            | 10 tablets  |
| EU/1/18/1300/006 | Duzallo      | 300 mg/200 mg | Film-coated tablet    | Oral use       | blister (PVC/PVDC/alu)            | 10 tablets  |

Medicinal product no longer authorised